ResearcherConsejo Nacional de Investigaciones Científicas y TécnicasActive in the last 2 years

Gisela Weiz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5808-6212; OpenAlex author ID A5071248817. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2024: 1 paper

Papers 1

Rutinosides-derived from Sarocladium strictum 6-O-α-rhamnosyl-β-glucosidase show enhanced anti-tumoral activity in pancreatic cancer cells. Co-author DOI 10.1186/s12934-024-02395-0 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Javier D. Breccia · 1 shared paper, 2024 · strength 0.26
- Paper Rutinosides-derived from Sarocladium strictum 6-O-α-rhamnosyl-β-glucosidase show enhanced anti-tumoral activity in panc… DOI 10.1186/s12934-024-02395-0 ↗
María Inés Molejon · 1 shared paper, 2024 · strength 0.26
- Paper Rutinosides-derived from Sarocladium strictum 6-O-α-rhamnosyl-β-glucosidase show enhanced anti-tumoral activity in panc… DOI 10.1186/s12934-024-02395-0 ↗
Martín E. Fernández-Zapico · 1 shared paper, 2024 · strength 0.26
- Paper Rutinosides-derived from Sarocladium strictum 6-O-α-rhamnosyl-β-glucosidase show enhanced anti-tumoral activity in panc… DOI 10.1186/s12934-024-02395-0 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.